protective agent
Showing 1 - 25 of 8,829
Post Stroke Epilepsy Trial in Changsha (idebenone 30 mg for 14 days, idebenone 30 mg for 3 months)
Recruiting
- Post Stroke Epilepsy
- idebenone 30 mg for 14 days
- idebenone 30 mg for 3 months
-
Changsha, Hunan, ChinaXiangya Hospital, Central South University
Aug 3, 2023
Cisplatin Adverse Reaction Trial in Tanta (cisplatin with hydration magnesium)
Enrolling by invitation
- Cisplatin Adverse Reaction
- cisplatin with hydration magnesium
-
Tanta, Gharbiya, EgyptMohamed Saad younis
Oct 25, 2022
Sepsis, Kidney Injury, Thiamine Deficiency Trial in United States (Thiamine Hydrochloride, Placebo)
Completed
- Sepsis
- +2 more
- Thiamine Hydrochloride
- Placebo
-
Boston, Massachusetts
- +3 more
Jul 29, 2022
The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive
Completed
- The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients
- Zingiber officinale L. tablets
- Simvastatin 20mg
-
Karachi, Sindh, PakistanAlkhidmat Hospital
Jan 11, 2023
Colorectal Cancer Trial in Los Angeles, Rancho Cucamonga (amifostine trihydrate, irinotecan HCl)
Completed
- Colorectal Cancer
- amifostine trihydrate
- irinotecan hydrochloride
-
Los Angeles, California
- +1 more
Jul 30, 2020
Head Neck Cancers - Nasopharyngeal Trial in Giza (photon therapy face mask)
Completed
- Head and Neck Cancers - Nasopharyngeal
- photon therapy face mask
-
Giza, Egyptfaculty of physical therapy , Cairo university
May 9, 2023
Plasmodium Falciparum Infection, Malaria Trial in Faladje, Kalifabougou, Torodo (L9LS (VRC-MALMAB0114-00-AB), Normal Saline)
Not yet recruiting
- Plasmodium Falciparum Infection
- Malaria
- L9LS (VRC-MALMAB0114-00-AB)
- Normal Saline
-
Faladje, Région De Koulikoro, Mali
- +2 more
Apr 17, 2023
Acute Ischemic Stroke Trial (Levofloxacin, Levofloxacin simulant)
Not yet recruiting
- Acute Ischemic Stroke
- Levofloxacin
- Levofloxacin simulant
- (no location specified)
Apr 5, 2023
Acute Ischemic Stroke Trial (Levofloxacin, Levofloxacin simulant)
Not yet recruiting
- Acute Ischemic Stroke
- Levofloxacin
- Levofloxacin simulant
- (no location specified)
Feb 14, 2023
Acute Ischemic Stroke Trial (Levofloxacin, Levofloxacin simulant)
Not yet recruiting
- Acute Ischemic Stroke
- Levofloxacin
- Levofloxacin simulant
- (no location specified)
Feb 14, 2023
Kidney Transplant, Type 2 Diabetes Trial in United States (Empagliflozin)
Not yet recruiting
- Kidney Transplant
- Type 2 Diabetes
-
Iowa City, Iowa
- +3 more
Aug 22, 2023
Vestibular Schwannoma Trial in Rochester (Omega-3, Placebo)
Recruiting
- Vestibular Schwannoma
- Omega-3
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 11, 2022
Coronary Artery Bypass Grafting, Coronary Artery Disease Trial (Melatonin, )
Not yet recruiting
- Coronary Artery Bypass Grafting
- Coronary Artery Disease
- Melatonin
- placebo
- (no location specified)
Sep 21, 2022
Depression Trial in Karachi (chamomile tea n saffron)
Active, not recruiting
- Depression
- chamomile tea n saffron
-
Karachi, PK, PakistanAga Khan University
Nov 16, 2022
Dental Erosion Trial in Pavia (SRP + toothpaste + mouthwash, SRP + toothpaste)
Completed
- Dental Erosion
- SRP + toothpaste + mouthwash
- SRP + toothpaste
-
Pavia, Lombardy, ItalyUnit of Dental Hygiene - Section of Dentistry - Department of Cl
May 11, 2022
Postoperative Delirium, Postoperative Cognitive Dysfunction Trial in Shanghai (Methylene Blue, Placebo)
Recruiting
- Postoperative Delirium
- Postoperative Cognitive Dysfunction
- Methylene Blue
- Placebo
-
Shanghai, ChinaShanghai Cancer Center, Fudan University
Dec 18, 2021
Malignant Lymphoma, Multiple Myeloma Trial (Pentaisomaltose)
Not yet recruiting
- Malignant Lymphoma
- Multiple Myeloma
- Pentaisomaltose
- (no location specified)
Jan 5, 2023
ARDS Trial in Nanjing (Sivelestat sodium, Placebo)
Recruiting
- ARDS
- Sivelestat sodium
- Placebo
-
Nanjing, Jiangsu, ChinaNanjing Zhong-Da Hospital, Southeast University
Dec 12, 2021
Chronic Lymphocytic Leukemia Trial in Lebanon (BNC105P, Ibrutinib)
Completed
- Chronic Lymphocytic Leukemia
- BNC105P
- Ibrutinib
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Jan 3, 2023
Anesthesia, Exhaled Nitric Oxide, Eosinophil Blood Count Trial in Athens (maintenance with sevoflurane, maintenance with
Completed
- Anesthesia
- +2 more
- maintenance with sevoflurane
- maintenance with propofol
-
Athens, GreeceAretaieion University Hospital
Jan 30, 2022
Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)
Not yet recruiting
- Esophageal Cancer
- +3 more
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, Cancer Institute and Hospital,
Jul 12, 2023
Brain Tumor, Metabolic Disturbance, Inflammatory Response Trial in Thessaloniki (Dexmedetomidine, Normal saline)
Completed
- Brain Tumor
- +3 more
- Dexmedetomidine
- Normal saline
-
Thessaloniki, GreeceAHEPA University Hospital
Feb 14, 2022